BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15364613)

  • 1. Functional heterogeneity of ryanodine receptor mutations associated with sudden cardiac death.
    Thomas NL; George CH; Lai FA
    Cardiovasc Res; 2004 Oct; 64(1):52-60. PubMed ID: 15364613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Ca2+ sensitivity of RyR2 mutations reveals distinct mechanisms of channel dysfunction in sudden cardiac death.
    Thomas NL; Lai FA; George CH
    Biochem Biophys Res Commun; 2005 May; 331(1):231-8. PubMed ID: 15845383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhythmogenic mutation-linked defects in ryanodine receptor autoregulation reveal a novel mechanism of Ca2+ release channel dysfunction.
    George CH; Jundi H; Walters N; Thomas NL; West RR; Lai FA
    Circ Res; 2006 Jan; 98(1):88-97. PubMed ID: 16339485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death.
    Jiang D; Wang R; Xiao B; Kong H; Hunt DJ; Choi P; Zhang L; Chen SR
    Circ Res; 2005 Nov; 97(11):1173-81. PubMed ID: 16239587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoplasmic reticulum Ca2+ measurements reveal that the cardiac ryanodine receptor mutations linked to cardiac arrhythmia and sudden death alter the threshold for store-overload-induced Ca2+ release.
    Jones PP; Jiang D; Bolstad J; Hunt DJ; Zhang L; Demaurex N; Chen SR
    Biochem J; 2008 May; 412(1):171-8. PubMed ID: 18092949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia.
    Marks AR; Priori S; Memmi M; Kontula K; Laitinen PJ
    J Cell Physiol; 2002 Jan; 190(1):1-6. PubMed ID: 11807805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ryanodine receptor mutations in arrhythmias: advances in understanding the mechanisms of channel dysfunction.
    Thomas NL; George CH; Williams AJ; Lai FA
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):946-51. PubMed ID: 17956252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant ryanodine receptors in catecholaminergic polymorphic ventricular tachycardia generate delayed afterdepolarizations due to increased propensity to Ca2+ waves.
    Paavola J; Viitasalo M; Laitinen-Forsblom PJ; Pasternack M; Swan H; Tikkanen I; Toivonen L; Kontula K; Laine M
    Eur Heart J; 2007 May; 28(9):1135-42. PubMed ID: 17347175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes.
    George CH; Higgs GV; Lai FA
    Circ Res; 2003 Sep; 93(6):531-40. PubMed ID: 12919952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ryanodine receptors and ventricular arrhythmias: emerging trends in mutations, mechanisms and therapies.
    George CH; Jundi H; Thomas NL; Fry DL; Lai FA
    J Mol Cell Cardiol; 2007 Jan; 42(1):34-50. PubMed ID: 17081562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyssynchronous (non-uniform) Ca2+ release in myocytes from streptozotocin-induced diabetic rats.
    Shao CH; Rozanski GJ; Patel KP; Bidasee KR
    J Mol Cell Cardiol; 2007 Jan; 42(1):234-46. PubMed ID: 17027851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calstabin deficiency, ryanodine receptors, and sudden cardiac death.
    Lehnart SE; Wehrens XH; Marks AR
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1267-79. PubMed ID: 15336974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RyR2 central domain peptide DPc10 lowers the threshold for spontaneous Ca2+ release in permeabilized cardiomyocytes.
    Yang Z; Ikemoto N; Lamb GD; Steele DS
    Cardiovasc Res; 2006 Jun; 70(3):475-85. PubMed ID: 16624262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac ryanodine receptor function and regulation in heart disease.
    Lehnart SE; Wehrens XH; Kushnir A; Marks AR
    Ann N Y Acad Sci; 2004 May; 1015():144-59. PubMed ID: 15201156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative splicing of ryanodine receptors modulates cardiomyocyte Ca2+ signaling and susceptibility to apoptosis.
    George CH; Rogers SA; Bertrand BM; Tunwell RE; Thomas NL; Steele DS; Cox EV; Pepper C; Hazeel CJ; Claycomb WC; Lai FA
    Circ Res; 2007 Mar; 100(6):874-83. PubMed ID: 17322175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcoplasmic reticulum calcium leak and cardiac arrhythmias.
    Chelu MG; Wehrens XH
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):952-6. PubMed ID: 17956253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia.
    Song L; Alcalai R; Arad M; Wolf CM; Toka O; Conner DA; Berul CI; Eldar M; Seidman CE; Seidman JG
    J Clin Invest; 2007 Jul; 117(7):1814-23. PubMed ID: 17607358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ modulation of the human cardiac ryanodine receptor (hRyR2) by FKBP12.6.
    George CH; Sorathia R; Bertrand BM; Lai FA
    Biochem J; 2003 Mar; 370(Pt 2):579-89. PubMed ID: 12443530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handling.
    Kirchhefer U; Wehrmeister D; Postma AV; Pohlentz G; Mormann M; Kucerova D; Müller FU; Schmitz W; Schulze-Bahr E; Wilde AA; Neumann J
    J Mol Cell Cardiol; 2010 Jul; 49(1):95-105. PubMed ID: 20302875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of abnormal calcium homeostasis in mutations responsible for catecholaminergic polymorphic ventricular tachycardia.
    Iyer V; Hajjar RJ; Armoundas AA
    Circ Res; 2007 Feb; 100(2):e22-31. PubMed ID: 17234962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.